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Abstract: Modulating oxidative stresses and inflammation can potentially prevent or alleviate the
pathological conditions of diseases associated with the nervous system, including ischemic optic
neuropathy. In this study we evaluated the anti-neuroinflammatory and neuroprotective activities
of Rhus coriaria (R. coriaria) extract in vivo. The half maximal inhibitory concentration (IC50) for
DPPH, ABTS and β–carotene were 6.79 ± 0.009 µg/mL, 10.94 ± 0.09 µg/mL, and 6.25 ± 0.06 µg/mL,
respectively. Retinal ischemia was induced by optic nerve crush injury in albino Balb/c mice.
The anti-inflammatory activity of ethanolic extract of R. coriaria (ERC) and linoleic acid (LA) on
ocular ischemia was monitored using Fluorescence Molecular Tomography (FMT). Following optic
nerve crush injury, the mice treated with 400 mg/kg of ERC and LA exhibited an 84.87% and 86.71%
reduction of fluorescent signal (cathepsin activity) respectively. The results of this study provide
strong scientific evidence for the neuroprotective activity of the ERC, identifying LA as one of the
main components responsible for the effect. ERC may be useful and worthy of further development
for its adjunctive utilization in the treatment of optic neuropathy.
Keywords: neuroprotection; Rhus coriaria; linoleic acid; ischemic optic neuropathy;
anti-neuroinflammation
1. Introduction
Optic neuropathy is a neurodegenerative disorder that involves damage to the optic nerve, which
can be caused by acute or intermittent insults leading to visual dysfunction. Axonal degeneration
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of optic nerve and loss of retinal ganglion cells are the main factors responsible for this disorder [1].
Ischemic optic neuropathy (ION) is the most common type of acute optic neuropathy in older
individuals and is caused by inadequate blood supply (ischemia) to the optic nerve [2,3].
The prevalence of ION in individuals over 50 years of age is 2–10 per 100,000 individuals [3].
The specific pathophysiology of ION has not yet been identified, but it is related to weak blood
flow throughout the optic nerve head. Ischemia-reperfusion injury refers to any clinical condition
involving inadequate oxygen consumption, such as stroke, trauma, shock, cerebral ischemia, or
ischemic optic neuropathy [4]. Initially, the similar reduction in blood flow in brain ischemia results
in a low concentration of oxygen and glucose. The resulting hypoxic conditions lead to repletion of
lactate through anaerobic glycolysis and generation of oxygen free radicals which contribute to cellular
apoptosis. Oxidative stress is believed to play a major part in the pathogenesis of optic neuropathy [1].
Apoptosis, or programmed cell death, is a method of cell loss during ischemia [5].
Free radicals results in upregulation of pro-inflammatory factors such as interleukins, platelet
activating factor, and tumor necrosis factor α [1]. The major factors involved in the molecular
mechanism of inflammation in neurodegenerative diseases like optic nerve degeneration are cytokins,
mitogen-activated protein kinase, nuclear factor kappa B (NF-κB), cyclooxygenases, lipoxygen, nitric
oxide synthase, and cathepsins [1]. Cathepsins constitute a family of proteases and inflammatory
response mediators that are associated with regulation of a type of cell death called caspase-dependent
cell apoptosis [2,3]. They have been shown to be a key initiator of apoptosis by directly activating
caspases [5,6]. Induction of an inflammatory response by reperfusion following ischemic tissue injury
may increase the intensity of damage [7].
There are several anti-inflammatory agents with neuroprotective effects, including aspirin
(acetylsalicylic acid (ASA)), the hydrogen sulfide-releasing derivatives of aspirin (ACS14
(2-acetyloxybenzoic acid 4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl ester)), and a latanoprost acid derivative
(ACS67) [1,8]. There is also evidence that supports the neuroprotective properties of sulfur compounds [9].
In recent years, several biological activities of polyphenols such as genistein have been described as
preventing the progression of cancer, cardiovascular diseases, diabetes, neurodegenerative diseases,
obesity, and aging [10,11]. Antioxidants and especially plant-derived antioxidants can play a role in the
control or deceleration of the progression of neurodegenerative disorders such as optic neuropathies,
glaucoma, Alzheimer’s disease, Parkinson’s disease, and ischemic or hemorrhagic stroke [1,12].
Rhus coriaria (R. coriaria), a medicinal plant belonging to the Anacardiaceae family, is widely grown
throughout the Mediterranean region. Historically, leaves and berries of R. coriaria were known to have
remarkable medicinal value in Middle Eastern herbal medicine [12]. Recent phytochemical studies of
berries of R. coriaria have proved the presence of various antioxidants including phenolics and fatty
acids [13]. Linoleic, gallic, oleic, palmitic, and stearic acids are the major components that have been
identified in the fruits of this herb in previous studies [12]. The role of R. coriaria as antidiarrheal,
anti-indigestion, anti-anorexia, antihemorrhagic, hyperglycemic, atheroprotective and neuroprotective,
properties have been previously assessed by in vitro and in vivo studies [5,12]. In the present study,
we evaluated the neuroprotective action of R. coriaria in an in vivo model of ION. The focus of this
research was to determine the role of R. coriaria on the factors involved in optic nerve degeneration
including oxidative stress, neuroinflammation, and cathepsin activity.
2. Experimental Section
2.1. Collection and Authentication of the Herb
R. coriaria samples were collected in the Taleghan region located 120 km northwest of Tehran, Iran.
The plant material was authenticated by a botanist, Dr. Rahmad Zakaria and submitted at Herbarium
Unit, School of Biological Sciences, University of Science Malaysia, where a voucher specimen was
deposited (reference# 11526).
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2.2. Preparation of R. coriaria Extract
The collected fruits were cleaned and dried at 35 ◦C for 24 h. To prepare the extract by the
maceration process, powder form of the dried herb was added to ethanol and subjected to maceration [5].
The mixture of herb and solvent was placed in a shaker for 48 h at room temperature to be mixed
gently using a magnetic stirrer. After cooling, the obtained solution was filtered using Whatman filter
paper and concentrated using a rotary evaporator (RE121 Buchi, New Castle, DE, USA) under vacuum.
The solvent was evaporated and removed, and the remaining material was freeze-dried (Labconco™,
Kansas City, MO, USA). The obtained extract was kept in sterile glass containers at 2 ◦C for further use.
2.3. Antioxidant Capacity Assays
2.3.1. ABTS (2,2′-Azino-Bis(3-Ethylbenzothiazoline-6-Sulphonic Acid) Radical Scavenging Assay
The total antioxidant capacity was assessed using a decolorization method described
previously [14]. ABTS radical cation (ABTS+) solution was prepared by mixing 7 mM ABTS with
deionised water. Fresh radicals were prepared by mixing 2.5 mL of 2.45 mM potassium persulfate
with 2.5 mL of 7 mM ABTS aqueous solution. Stock solutions of the test extract (ethanolic extract of
R. coriaria (ERC)) and standard (ascorbic acid) were prepared in methanol. The tested extract (0.1 mL)
at different concentrations was added to 0.9 mL ABTS+ solution, and the absorbance was measured at
734 nm after 6 min. For the negative control, 0.9 mL of ABTS+ was mixed with 0.1 mL of methanol.
All tests were performed in triplicate.
2.3.2. DPPH (2-Diphenyl-1-Picrylhydrazyl) Scavenging Assay
The assay was performed using a previously described method [15]. Stock solution of the ERC was
prepared in methanol and diluted to different concentrations in the range of 1 to 30 µg/mL. In a test tube,
2.5 mL of different concentrations of test samples dissolved in MeOH:H2O (1:1) were added to 1 mL of
0.3 mM DPPH prepared in methanol. For the negative control, 2.5 mL of methanol were mixed with
1 mL of 0.3 mM DPPH. The mixture was reacted at 25± 2 ◦C for 30 min, after which the absorbance was
measured at 517 nm using the microplate reader (TECAN Infinite Pro® M200, Männedorf, Switzerland),
and the amount of remaining DPPH was determined. The experiment was performed in triplicate.
2.3.3. B-Carotene Bleaching Assay
The β-carotene/linoleic acid (LA) emulsion was used to measure the β-carotene oxidation
and free radical scavenging action of the extract [16]. First, 2 mg of β-carotene were dissolved
in 10 mL of chloroform. Then, 1 mL of β-carotene solution was mixed with 20 mg of purified LA
and 200 mg of Tween 40 emulsifier in a round-bottom flask. Rotary vacuum evaporator was used
to remove chloroform. Distilled water (50 mL) was added to the flask and the mixture was stirred
with a vortexer. Aliquots of this emulsion were mixed with different concentrations of the ERC.
Butylated hydroxytoluene (BHT) was used as the reference standard. The samples were shaken and
incubated at 50 ◦C in a water bath. The zero time absorbance was assessed at 470 nm using a microplate
reader and recorded at 20 min intervals. The assays were performed in triplicate.
2.4. Characterization of the Extract
2.4.1. Estimation of Total Phenolic Content
The total phenolic content of the extract was determined using a colorimetric assay. Gallic acid was
used as the standard reference. A series of concentrations of gallic acid (1 to 30 µg/mL) was prepared
in distilled water, and 1 mL of each concentration was mixed with 0.5 mL of Folin-Ciocalteu reagent.
The test tube was kept for 4 min at room temperature (25 ± 2 ◦C) after shaking. The sample was mixed
with 1 mL of 20% (w/v) solution of Na2CO3 and 6 mL of distilled water, shaken, and kept in a dark room
for 2 h at 25 ± 2 ◦C. The absorbance was read at 765 nm using the microplate reader. A stock solution
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of 1 mg/mL of the ERC was prepared in methanol and diluted, obtaining different concentrations (1, 5,
10, 20 and 30 µg/mL). The results are expressed as µg gallic acid equivalents per gram of the extract (µg
GAE/g extract). The results of three experiments are presented as mean ± SEM (standard error).
2.4.2. Total Flavonoids Assay
Quercetin was used as the standard reference in the colorimetric method used to determine total
flavonoid content [17]. A stock solution of 2 mg/mL of the ERC and 1 mg/mL of the standard was
prepared in methanol. The volume of 1 mL of each concentration of the standard solution (1–30 µg/mL
in distilled water) and the test extract solution were mixed with 4 mL of distilled water and 0.3 mL of 5%
sodium nitrite solution (NaNO2), respectively. After standing for 5 min at 25± 2 ◦C, 0.3 mL of aluminum
chloride (10% solution) was added to the mixture in a 10 mL volumetric flask. Next, 2 mL of 1 M NaOH
were added and the total volume was increased to 10 mL by adding distilled water. The absorbance was
read at 510 nm using the microplate reader. The results are expressed as µg quercetin equivalents per
gram of the extract (µg QE/g extract). The results of three experiments are reported as mean ± SEM.
2.4.3. Gas Chromatography-Mass Spectrometry (GC-MS) Screening
GC-MS analysis is used to evaluate the various phytoconstituents obtained from different extraction
procedure [18]. An Agilent GC-MS (6890N/5973I) coupled with electrospray ionization and a single
quadrupole detector was used to separate the various phytoconstituents using an HP-5 MS capillary
column (0.25 mm× 30 m× 0.25 µm film thickness). The temperature of oven was retained at 70 ◦C for
2 min and enhanced at 20 ◦C/min to 305 ◦C and retained there for 1 min. Helium gas with a flow rate of
1.2 mL/min was used as the carrier gas, and 1 µL of the sample was injected into the GC-MS for analysis.
The MS electrospray ion source operated at 70 eV, and the acquisition range was between 35 and 700 m/z
with a scan rate of 1 scan/s. The presence of chemical constituents in the extract was confirmed by referring
to the NIST (national institute of standards) library of the system and by their retention indexes.
2.5. In Vivo Study of the Mouse Ischemic Optic Neuropathy Model
2.5.1. Animal Studies
The Animal Ethics Committee of the University of Science Malaysia approved the study involving
mice. The animals were obtained from the Animal House Unit, University of Science Malaysia.
In handling the animals, all procedures were carried out following the Animal Ethics Guidelines
of University of Science Malaysia (USM/Animal Ethics Approval/2013/(90) (543), 11/12/2013).
Grouping and numbers of mice were as follows: 15 male mice, aged 8–12 weeks, were divided into
five groups (n = 3) for positive control, negative control, and three groups of test animals).
2.5.2. Animal Treatment
The three test groups of animals were administered orally with: (i) 200, (ii) 400 mg/kg body
weight of the ERC, and (iii) 400 mg/kg of LA, once a day for 10 days before performing an optic nerve
crush injury. The two control groups received just the normal diet.
2.5.3. Optic Nerve Crush Injury
An optic nerve ischemia procedure was performed on the negative control group and the three
treated groups after anesthetizing the mice with ketamine (90 mg/kg body weight) and xylazine
(10 mg/kg body weight) via intraperitoneal injection. In the left eyes of animals, the ocular muscles
around the eyeball and optic nerve were held apart with forceps. Then the 10-0 surgical suture was
used to make crush lesions. One end of suture was kept near the optic nerve with forceps and the
other end was pulled with a weight to constrict it for 60 s and then it was released [19]. In this way
the retinal ischemia was induced by interruption of the blood flow through the ophthalmic vessels.
The animals subjected to ischemia were kept in normal condition in animal house.
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2.5.4. Fluorescence Molecular Tomography (FMT) Imaging
The FMT 2000 (Fluorescence Tomography System, PerkinElmer, Waltham, MA, USA) was used
for this study. Preparation for FMT imaging began 24 h after optic nerve injury and induction of
ocular ischemia. Animals in all five groups were injected intravenously via a tail vein with 1 nmol
ProSense 750 EX (VisEn Medical, Bedford, MA, USA) in 200 µL of saline. Twenty-four hours after
the ProSense injection, they were anesthetized and imaged by FMT. This system was able to detect
fluorescence and resolve the probe signal in the targeted region. The mouse was placed horizontally
on a fixed stage at a known distance from a camera. For acquisition of the data sets a fluid was
added to the imaging chamber and then the data reconstructions were run on the system within 24 h.
The three-dimensional regions of interest (ROI) were selected using the software supplied with the
instrument (WinLight32, Berthold Technologies, Bad Wildbad, Germany). The ROI data were collected
and exported to Microsoft Excel for data analysis [20].
2.6. Statistical Analysis
Statistical analyses were carried out with Microsoft Excel and Sigma Plot software version 13.0.
Comparisons between test and control groups were made using t-tests. Data were expressed as a mean
percentage of the control plus SEM, and p-value < 0.05 was considered to be significant.
3. Results
3.1. ABTS Radical Scavenging Assay
The ERC had effective free radical scavenging ability (Figure 1a), as indicated by the IC50
value of 10.94 ± 0.09 µg/mL (n = 3, p-value < 0.001). The IC50 of the standard (ascorbic acid) was
4.97 ± 0.056 µg/mL. The ability of the ERC to scavenge ABTS radical (ABTS+) was noted to be very
significant compared to the control. The ability of ERC to quench ABTS+ is an evidence for its action in
preventing oxidative damages caused by free radicals.
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3.2. DPPH Scavenging Assay
Figure 1b shows the c ncentration-response curve of the effect of the ERC on DPPH scavenging
activity. The percentage of DPPH scavenging activity of the extract is represented as m an ± SEM.
Serial dilution of the extract concentration to 1, 5, 10, 20, a d 30 µg/mL was used throughout the
experiment. The results showed that the extract possessed potent scavenging ability, as it reduced
the purple DPPH reagent to yellow by donating its hydrogen. The extract quenched DPPH in a
concentration-dependent manner. The IC50 of DPPH scavenging activity was 6.79± 0.009 µg/mL (n = 3,
p-value < 0.05), whereas that of the standard Rutin used in clinical practice was 3.23 ± 0.019 µg/mL.
3.3. β-Carotene Bleaching Assay
Figure 1c shows the results of the β-carotene bleaching activity. The low IC50 value of
6.25 ± 0.06 µg/mL (n = 3, p-value < 0.05) shows that the ERC i hibited β-carotene bleaching
and that it h d high r dical scavenging activity. BHT as used as the sta dard, and its IC50 was
0.89 ± 0.039 µg/mL. This result demonstrates that ERC can act as a hydrogen-donating antioxidant
to slow down the oxidation and β-carotene bleaching. A 50% reduction of the yellowish color of
β-carotene by the extract was seen at 6.25 ± 0.06 µg/mL.
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3.4. Assays for Total Phenolics and Total Flavonoids Content
In an effort to reveal the chemical components that give rise to the antioxidant activities of
the ERC, phytochemical screening was undertaken, including an assessment of total phenolics and
flavonoids. Table 1 summarizes the amounts of total flavonoids and phenolics present in the ERC
extract. The total phenolic content was higher (9353 ± 83 µg GAE/g) than the total flavonoid content
(1393 ± 32 µg QE/g) (Table 1). Phenolic compounds can play a major role in the prevention of various
pathological conditions, including neurodegenerative diseases, by neutralizing chemically active
oxidants [1]. It can thus be argued that the antioxidant activity of the ERC correlates directly with the
demonstrated presence of phenolics and flavonoids.
Table 1. Phytochemical contents of the R. coriaria ethanol extract (ERC). The data are means± SEM (n = 3).
Test Sample Total Phenolics (µg GAE/g) Total Flavonoids (µg QE/g)
ERC 9353 ± 83 1393 ± 32
3.5. GC-MS
The GC-MS method employed in this study was performed to further characterize for the chemical
constituents present in the extract (Figure 1d). The presence of chemical components was confirmed by
referring to the national institute of standards and technology (NIST) library of the system and by the
retention indexes. In general, the GC-MS method applied was functional in screening unknown plant
extracts. The chemical compounds found in the extract are listed in Table 2. LA (9,12-octadecadienoic
acid (Z,Z)-) (12.39%), γ-sitosterol (11.95%), campesterol (9.32%), stigmasta-5,24(28)-dien-3-ol (8.95%),
and octadecane (7.85%) were the major constituents.
Table 2. GC-MS screening of the phytochemicals present in the R. coriaria ethanol extract.
Peak Compound Ref Quality Peak Height R.T. Min % Area RI
a Tricosane 114376 99 1,192,748 11.118 2.65% 1408.8
b Heptacosane 113306 99 826,548 11.16 1.87% 1496.4
c Nonacosane 116666 98 451,294 11.229 1.03% 1632.8
d Octadecane 106289 95 680,873 11.514 7.85% 2195
e Campesterol 130016 97 5,389,423 11.944 9.32% 2298.8
f 8,11-Octadecadienoic acid, methyl ester 136481 97 607,878 12.361 1.10% 2398.4
g γ-Sitosterol 136487 98 6,507,080 12.777 11.95% 2497.9
h 9,12,15-Octadecatrienoic acid, methyl ester 91035 96 331,695 13.235 0.90% 2599.5
i Linoleicacid (LA) (9,12-Octadecadienoic acid (Z,Z)-) 151555 99 5,171,060 13.756 12.39% 2697.9
j Stigmasta-5,24(28)-dien-3-ol 158131 99 2,634,496 15.054 8.95% 2945.6
3.6. FMT Imaging
Imaging by three-dimensional FMT was performed to quantify the inflammatory molecular
response at the site of ischemic injury in the injured optic nerve and the protective role of ERC and
LA (Figure 2). In our experiment, none of the animals in the five groups died during the experiments.
After imaging, the images and data sets were analyzed before and after selecting the ROI. To measure
the induced optic nerve ischemia, the images were focused on anatomical positions specific to the
eye (Figure 3). There was no increase in fluorescence signal from the normal control group (Figures 3
and 4), which indicated that pan-cathepsins were not being activated in the normal mouse optic nerve.
Data analysis revealed significant differences between in vivo FMT signal intensities of treated
groups and the negative control, even before ROI selection (Figure 2). The reductions in fluorescence
volume in the ROI for the group treated once a day for 10 days with 200 and 400 mg/kg of the ERC were
exported and measured (Figure 4). The average fluorescence intensity within the ROI of the left eye
after induction of ischemia for the negative control was 659.32± 123.57 mm2, for the group treated with
200 mg/kg of the ERC it was 253.56± 57.64 mm2, and for the group treated with 400 mg/kg of the ERC
it was 99.30 ± 40.28 mm2. In contrast to the negative control, 61.54% and 84.87% inhibition of ischemia
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were exhibited in the groups treated with 200 and 400 mg/kg of the ERC, respectively (Table 3). For the
group treated with 400 mg/kg of LA, the average fluorescence intensity after induction of ischemia was
87.20 ± 50.12 mm2. LA exhibited 86.71% inhibition of ischemia in comparison with the negative control.
Table 3. Comparison of fluorescence intensity (mm2) and % of ischemia inhibition in treated and
control groups.
Test Fluorescenceintensity (mm2) (Mean) SEM % Inhibition Ofischemia
Normal control 69.66 48.56 —
Ischemia (negative control) 659.32 123.57 —
ERC 200 mg/kg 253.56 57.64 61.54
ERC 400 mg/kg 99.30 40.28 84.87
LA 400 mg/kg 87.20 50.12 86.71
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Figure 2. Fluorescence molecular tomography images without the region of interest (ROI). In this figure,
the ROI area was not selected, but the differences in fluorescence intensities between the negative
control (b) and the treated groups (c–e) is obvious. The negative control was the animal with induced
ischemia at the left optic nerve/eye. The untreated normal animal was used as the positive/normal
control (a). ProSens 750 was used as the inflammatory (cathepsin) fluorescent probe. In the group
treated with 400 mg/kg body weight of ERC (d) and LA (e), the cathepsin fluorescence signal was
significantly lower than that of the negative control.
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For the ischemia-induced group (negative control), FMT signals recorded high fluorescence
intensities of 659.32 ± 123.57 mm2. The high fluorescence signal in the damaged area was in response
to activation of the probe by binding to cathepsin. This is indicative of initiation and promotion of
neural damage. In the mice treated with 200 and 400 mg/kg of the ERC, the signal intensities of this
fluorescent probe were significantly lower (253.56 ± 57.64 mm2 and 99.3 ± 40.28 mm2, respectively;
Figure 4), which supports the in vivo neuroprotective efficacy of the ERC.
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Figure 3. Fluorescence molecular tomography images with the region of interest (ROI). The ROI
proximal to the eye area was selected to focus on the ischemic eye. In the negative control (b), the
fluorescence signal was very intense (white arrow), whereas, in the treated ischemic eyes, treatment
with LA (e) and different concentrations of ERC (c,d) reduced the fluorescence signal of the ROI.
The image of the normal/positive control was used as the background.
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Figure 4. Graphical representation of the intensity of the fluorescence signal generated after induction
of ischemia. Animals treated with ERC and LA exhibited a significant reduction in the ischemia-induced
signal compared to the untreated group (control). Data are expressed as mean ± SEM (n = 3),
* p-value < 0.05, ** p-value < 0.01.
4. Discussion
The present study explored the neuroprotective potential of R. coriaria fruit extract using an
array of studies to define the characteristic features and the biological target(s) that contributed to
neuroprotection in an in vivo model of ION. Alcohols are frequently used as solvents to extract various
bioactive ingredients such as phenolics and flavonoids [21]. The antioxidant property of the ethanolic
extract of R. coriaria (ERC) was tested using several assays.
The identification and characterization of major components of R. coriaria fruit extract has been
performed in previous studies [22,23]. In this study, GC-MS analysis was performed to screen the
major constituent(s) of the ERC that are responsible for its neuroprotective activity. The GC-MS method
applied in this study proved useful in screening unknown components in the extract tested as well
as providing a view of the existence of an abundance of polar compounds. The major fatty acids
found in the extract were derivatives of the polar fatty acid including LA, which is in agreement
with literature [24]. LA constituted 12.39% of the total content of the extract and has been shown to
possess neuroprotective and antioxidant activities. γ-sitosterol was present at 11.95%, which is also
a common chemical constituent of several neuroprotective herbs such as Vitis vinifera, Ginkgo biloba,
and Bacopa monnieri [25]. Campesterol and stigmasta-5,24(28)-dien-3-ol were present at 9.32% and
8.95%, respectively. They have also been detected in other herbal extracts with potent neuroprotective,
antioxidant, and anti-inflammatory activities [26].
To assess the effects of the ERC on recovery after ischemia, different concentrations of the extract
were tested for protective effects against ischemia in a mouse ION model; for details please refer
to methods section. Studies of retinal ischemia can be simulated using a number of in vivo models.
The albino Balb/c mouse, for example, is easy to handle and has a suitable retinal vasculature
construction with similarities to humans. The goal of optic nerve crush method to induce ischemia
caused by reduced blood supply to axons, leading to axonal damage [27]. We divided the animals
into five groups: (i) positive control not injured without receiving any treatment; (ii) negative control
injured without receiving any treatment; (iii) injured and treated with 200 mg/kg body weight of
ERC; (iv) injured and treated with 400 mg/kg body weight of ERC; and (v) injured and treated with
400 mg/kg body weight of LA once a day for 10 days. The imaging probe used in this experiment was
the pan-cathepsin fluorescent ProSense 750, which can be activated by cathepsins B, L, S, K, V, and D
and turn into a highly fluorescence signal [28]. Cathepsins act as mediators of lysosomal proteases in
apoptosis processes. Reactive oxygen species-dependent activity on cathepsin stimulation has also
been demonstrated in studies of caspase-dependent apoptosis [29].
The significant antioxidant and the inhibition of the inflammatory mediator cathepsin by the
ERC in response to neuronal ischemic injury provide supporting evidence of the neuroprotective
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property of the ERC. The high percentage of anti-inflammatory activity exhibited by the ERC in this
study was perhaps due to the high content of phenolic compounds and the chemical constituents
screened by GC-MS (Table 2). On the other hand, our results showed that, at the concentration of
400 mg/kg, LA was more effective (86.71%) than ERC (84.87%) at inhibiting ischemia, but there
was no significant difference between them. We can, therefore, suggest that LA, a major component
in ERC, may contribute significantly to the observed pharmacological activity. In support of the
present findings, extensive studies have demonstrated the neuroprotective effect of LA and phenolic
compounds in neurodegenerative disease models [30].
5. Conclusions
In this study, the ethanol extract of R. coriaria was prepared and evaluated for its neuroprotective
effects in vivo. The antioxidant capacity of the ERC was demonstrated by different assays, including
DPPH, ABTS, and β-carotene bleaching tests. In the central nervous system, a stroke occurs as a result
of the reduction or blockage of blood flow in the affected region, leading to ischemic damage of neurons
and other cells. In the present study, the interruption of blood circulation and induced axonal lesion to
the optic nerve axon in the mouse model of ischemic optic neuropathy was carried out as a proof of the
concept. In chemical screening studies of the extract, GC-MS and phytochemical analysis were used
to reveal the presence of secondary metabolites (phenolics and flavonoids). The active compounds
reported in the extract were LA, γ-sitosterol, campesterol, and stigmasta-5,24(28)-dien-3-ol, which have
been previously identified as active constituents of herbal extracts with antioxidant, anti-inflammatory
and neuroprotective properties [25].
Using the optic nerve crush method, the extract was found to inhibit the inflammatory response
to ischemia-reperfusion in vivo by inhibiting the activity of the inflammatory mediator cathepsin.
One of its major components, LA exhibited a comparable inhibitory effect on ischemia. LA may play
an important role in its anti-inflammatory potential, and this mechanism may be partly responsible
for its efficacy. The results of this study provide scientific evidence for the neuroprotective activity
of the ERC. It is plausible, therefore, to conclude that the ERC may be useful and worthy of further
development for its adjunctive use in the treatment of neurodegenerative diseases including ischemic
optic neuropathy. Nevertheless, further toxicological studies must be carried out to evaluate its safety
and potential hazards.
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